|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flow From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: | |||||
| (Gain) loss on sale or write down of assets | |||||
| Gain on foreign currency transactions | |||||
| Loss on early extinguishment of debt | |||||
| Depreciation and amortization | |||||
| Provision for bad debts | |||||
| Equity in income from unconsolidated joint venture | |||||
| Distribution of income from unconsolidated joint ventures | |||||
| Changes in assets and liabilities, net of acquisitions and dispositions: | |||||
| Other assets | |||||
| Related party receivables | |||||
| Accrued interest payable | |||||
| Accounts payable and other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flow From Investing Activities: | |||||
| Collection of notes receivable | |||||
| Originations and advances on notes receivable | |||||
| Purchase of short-term investments | |||||
| Redemption and/or maturities of short-term investments | |||||
| Development and renovation of real estate | |||||
| Deferred leasing costs | |||||
| Proceeds from sale of assets | |||||
| Contribution to unconsolidated joint venture | |||||
| Distributions from unconsolidated joint venture | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flow From Financing Activities: | |||||
| Proceeds from mortgages and other notes payable | |||||
| Payments on mortgages, other notes and bonds payable | |||||
| Purchase of IOR shares | |||||
| Debt extinguishment costs | |||||
| Deferred financing costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...